September 28, 2020
Johns Hopkins researchers develop system for using everyday glucose monitors to detect COVID-19 antibodies
A trio of Johns Hopkins scientists—a pharmacologist, a biomedical engineer, and a biophysicist—are pooling their knowledge to design a device that can detect whether a person has antibodies linked to SARS-CoV-2, the virus that causes COVID-19.
September 24, 2020
Septic shock starts earlier than understood and develops distinct levels of patient risk, study suggests
A new study from Johns Hopkins biomedical engineers finds that hospitals could categorize patients based on risk and develop early monitoring systems to detect early stages of septic shock.
September 10, 2020
Geneticists could identify the causes of disorders that currently go undiagnosed if standard practices for collecting individual genetic information were expanded to capture more variants that researchers can now decipher.
August 26, 2020
Scientists at Johns Hopkins Medicine using MRI scans and computer modeling say they have further pinpointed areas of the human brain that regulate efforts to deal with fatigue.
August 25, 2020
René Vidal, the Herschel L. Seder Professor in Johns Hopkins Department of Biomedical Engineering, is leading a team of engineers, mathematicians, and theoretical computer scientists from multiple institutions who seek to revolutionize our understanding of the mathematical and scientiﬁc foundations of deep learning.
July 10, 2020
Engineers at Johns Hopkins have solved the problem of distorted imaging scans that plague surgeons who need to use them to assess the placement of metal implants.
July 7, 2020
In experiments in rats and mice, two Johns Hopkins scientists — an engineer and an ophthalmologist — report the successful use of nanoparticles to deliver gene therapy for blinding eye disease.
June 10, 2020
Johns Hopkins scientists studying the virus that causes COVID-19 say the pathogen has few variations, a promising observation that boosts the chances of developing an effective vaccine.
May 20, 2020
A team of researchers and students at Johns Hopkins are working to replenish the diminishing reserve of kidney dialysis fluid to help those with acute kidney injury, including COVID-19 patients who develop the disorder.
May 19, 2020
Johns Hopkins researchers report they have identified a drug treatment that could—if given early enough—potentially reduce the risk of death from the most serious complication of COVID-19, also known as SARS-CoV-2 infection.